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Ultrasonographic Findings of Medullary
Thyroid Carcinoma: a Comparison with
Papillary Thyroid Carcinoma
Objective: This study was designed to evaluate the ultrasonographic (US) find-
ings of medullary thyroid carcinoma (MTC) as compared to findings for papillary
thyroid carcinoma (PTC). 
Materials and Methods: The study included 21 cases of MTC that were surgi-
cally diagnosed between 2002 and 2007 and 114 cases of PTC that were diag-
nosed in 2007. Two radiologists reached a consensus in the evaluation of the US
findings. The US findings were classified as recommended by the Thyroid Study
Group of the Korean Society of Neuroradiology and Head and Neck Radiology
(KSNHNR) and each nodule was identified as suspicious malignant, indetermi-
nate or probably benign. The findings of medullary and papillary carcinomas were
compared with use of the chi-squared test.
Results: The common US findings for MTCs were solid internal content (91%),
an ovoid to round shape (57%), marked hypoechogenicity (52%) and calcifica-
tions (52%). Among the 21 cases of MTC nodules, 17 (81%) were classified as
suspicious malignant nodules. The mean size (longest diameter) of MTC nodules
was 19  13.9 mm and the mean size (longest diameter) of PTC nodules was 11
7.4 mm; this difference was statistically significant (p < 0.05). An ovoid to
round shape was more prevalent for MTC lesions than for PTC lesions (p < 0.05).
Conclusion: The US criteria for suspicious malignant nodules as recommend-
ed by the Thyroid Study Group of the KSNHNR correspond to most MTC cases.
The US findings for MTC are not greatly different from PTC except for the preva-
lence of an ovoid to round shape.
edullary thyroid carcinoma (MTC) accounts for 3.5-10% of all thyroid
malignancies (1) and lesions are derived from the parafollicular C-cells
that produce calcitonin (2). The serum calcitonin level is known as a
sensitive and specific marker for MTC. However, not all MTCs secrete calcitonin (3),
and hypercalcitoninemia is known to be associated with chronic thyroiditis and C-cell
hyperplasia in addition to MTC (4). Routine measurement of plasma calcitonin levels
in patients who have thyroid nodules has not been widely adopted (5). Therefore,
knowledge of the imaging characteristics of MTC is as important as the serum
calcitonin level for the early detection and precise diagnosis of MTC. Numerous
studies that have evaluated the ultrasonographic (US) findings of malignant thyroid
nodules have been conducted (6-11). Most studies have focused on papillary thyroid
carcinomas (PTCs), which account for more than 70% of all malignant nodules (10-
13). Studies that have evaluated the US findings of MTC are rare (14, 15). In this
study, we have evaluated the US findings of MTC as compared with the US findings of
PTC.
Sung-Hun Kim, MD
1
Bum-Soo Kim, MD
1
So-Lyung Jung, MD
1
Jung-Whee Lee, MD
1
Po-Sung Yang, MD
1
Bong-Joo Kang, MD
1
Hyun-Wook Lim, MD
1
Jee-Young Kim, MD
1
In-Yong Whang, MD
1
Heuk-Sang Kwon, MD
2
Chan-Kwon Jung, MD
3
Index terms:
Thyroid
Thyroid, neoplasms
Thyroid, US
DOI:10.3348/kjr.2009.10.2.101
Korean J Radiol 2009;10:101-105
Received January 15, 2008; accepted 
after revision September 30, 2008.
Departments of 
1Radiology, 
2Internal
Medicine and 
3Pathology, College of
Medicine, The Catholic University of
Korea
Address reprint requests to:
Bum Soo Kim, MD, Department of
Radiology, Kangnam St. Mary’s Hospital,
The Catholic University of Korea, 505
Banpo-dong, Seocho-gu, Seoul 137-040,
Korea.
Tel. (822) 590-1580
Fax. (822) 599-6771
e-mail: bumrad@catholic.ac.kr
MMATERIALS AND METHODS
Patients
This study included 21 cases (18 patients; 15 females and
3 males; age range, 26-70 years; mean patient age, 55
years) that were surgically diagnosed as an MTC between
2002 and 2007. Three patients had bilateral MTCs (16.7%).
Sixteen patients had a sporadic MTC, and two patients had
type IIa multiple endocrine neoplasia (MEN). One MEN
type IIa patient had bilateral adrenal pheochromocytomas
and another patient had bilateral adrenal hyperplasia. The
basal calcitonin level of the 15 MTC patients was measured
prior to surgery and in 14 patients the serum calcitonin
level was elevated (range, 24.7-355 pg/mL; median level,
171.4 pg/mL); the normal range for an immunoradiometric
assay is 10 pg/mL. As the MTC US findings of MTC were to
be compared with the PTC US findings, a, control group of
114 PTC cases that were surgically diagnosed during 2007
(99 patients; 85 females and 14 males; age range, 27-76
years; mean age, 50.4 years) was established. Fifteen
patients had bilateral PTCs (13.2%).
US Imaging
High resolution US examinations of the thyroid were
performed with a HDI 3000 scanner (Advanced
Technology Laboratories, Philips Medical Systems, Bothell,
WA) and a HDI 5000 scanner (Philips Medical Systems)
equipped with a 5-10 MHz linear array transducer.
Examinations were performed by radiology residents and
by the radiologists in charge of thyroid imaging (with one
to 16 years of experience). 
Imaging Analysis and Statistical Analysis
The US images were analyzed retrospectively in a blind
review by two radiologists in charge of thyroid imaging
with two and 16 years of experience, respectively. By
summarization of the classifications of US findings (size,
internal content, shape, margin, echogenicity and calcifica-
tions) as recommended by the Thyroid Study Group of the
Korean Society of Neuroradiology and Head and Neck
Radiology (KSNHNR), each nodule was identified as
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Table 1. Comparison of Ultrasonographic Findings of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma
Ultrasonographic Findings
Medullary Carcinoma Papillary Carcinoma
P value
(n = 21) (n = 114)
Lesion size 19  13.9 mm 11  7.5 mm < 0.05
Internal content
solid 19 (90.5%) 110 (96.5%) 0.219
predominantly solid 2 (9.5%) 04 (3.5%)
predominantly cystic 0 (0%)0. 0 (0%).
cystic 0 (0%)0. 0 (0%).
Shape
ovoid to round 12 (57.1%) 029 (25.4%) < 0.05
*taller than wide 04 (19.0%) 048 (42.1%)
irregular 05 (23.8%) 037 (32.5%) 
Margin
smooth 04 (19.0%) 022 (19.3%) 0.964
*spiculated 09 (42.8%) 044 (38.6%)
ill-defined 08 (38.1%) 048 (42.1%)
Echogenicity
*markedly hypoechoic 11 (52.4%) 065 (57.0%) 0.894
hypoechoic 09 (42.9%) 042 (36.8%)
isoechoic 1 (4.8%) 05 (4.4%)
hyperechoic 0 (0%)0. 02 (1.8%)
Calcifications
no calcifications 10 (47.6%) 037 (32.5%) 0.348
*microcalcifications 06 (28.6%) 053 (46.5%)
*macrocalcifications 05 (23.8%) 021 (18.4%)
rim calcifications 0 (0%)0. 03 (2.6%)
Note ─ *If nodule had any one of these features on ultrasonography, it was classified as suspicious malignant nodule.suspicious malignant, indeterminate or probably benign
(6). An analysis for distant or regional metastases, includ-
ing lymph node metastases, was not performed in this
study. With respect to the size of the nodules, the longest
diameter measured by US was selected and was expressed
as the mean ± standard deviation.
The internal contents of the nodules were defined as
solid (a solid component more than 90%), predominantly
solid (a solid component more than 50% but less than
90%), predominantly cystic (a solid component more than
10% but less than 50%) and cystic (solid component less
than 10%). The shape of nodules was defined as ovoid to
round, taller than wide (the anteroposterior dimension was
longer than the transverse diameter), or irregular (neither
round to oval nor taller than wide). The border characteris-
tics were defined as smooth, spiculated or ill defined.
Echogenicity was defined as markedly hypoechoic (less
than the strap muscle echogenicity), hypoechoic (less than
the thyroid echogenicity), isoechoic (equal to the thyroid
echogenicity) or hyperechoic (greater than the thyroid
echogenicity). Calcifications were defined as microcalcifica-
tions (tiny punctate hyperechogenicities either with or
without acoustic shadowings of less than 1 mm in
diameter), macrocalcifications (larger than 1 mm in
diameter) or rim calcifications. Malignant sonographic
characteristics were defined as a shape that was taller than
wide, with a spiculated border, marked hypoechogenicity
and micro calcifications or macrocalcifications. If a nodule
had any one of these features that are suggestive of a
malignancy, the lesion was classified as a suspicious
malignant nodule. A probably benign nodule was classified
as either completely cystic or predominantly cystic with a
comet tail artifact. An indeterminate nodule was defined as
a nodule that was not suspicious for malignancy or showed
probably benign findings. The findings of medullary and
papillary carcinomas were compared with use of the chi-
squared test. A p-value of less than 0.05 was defined as
statistically significant.
RESULTS
The US findings of the MTCs and PTCs are summarized
in the Table 1. For the MTCs, a solid internal content (19
of 21, 90.5%), ovoid to round shape (12 of 21, 57.1%),
marked hypoechogenicity (11 of 21, 52.4%), microcalci-
fications or macrocalcifications (11 of 21, 52.4%) and a
spiculated or ill-defined margin (17 of 21, 80.9%) were the
prevailing findings seen on US. For 21 MTCs, 17 (81%)
were categorized as suspicious malignant nodules, and four
(19%) were categorized as indeterminate nodules (Figs. 1,
2). None of the lesions were categorized as probably
benign nodules. For the PTCs, the prevailing findings as
seen on US were a solid internal content (110 of 114,
96.5%), taller than wide shape (48 of 114, 48%), irregular
border (48 of 114, 42.1%), marked hypoechogenicity (65
of 114, 57.0%) and microcalcifications or macrocalcifica-
tions (74 of 114, 64.9%). For 114 PTCs, 107 (94%) were
categorized as suspicious malignant nodules and seven
(6%) were categorized as indeterminate nodules (Fig. 3).
The mean size (19  13.9 mm vs. 11  7.5 mm) and
ovoid to round shape (57.1% vs. 25.4%) were statistically
different between the MTCs and PTCs. However, the
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Fig. 1. Ultrasonography performed on 55-year-old female with
medullary thyroid carcinoma.
Sagittal scan shows 13 mm, solid, ovoid to round, markedly
hypoechoic nodule with spiculated border (arrows) and internal
macrocalcifications. This nodule was classified as suspicious
malignant.
Fig. 2. Ultrasonography performed on 61-year-old female with
medullary thyroid carcinoma.
Transverse scan shows 18 mm, solid, ovoid to round, hypoechoic
nodule with smooth border. This nodule was classified as indeter-
minate.internal content, margin, echogenicity and calcifications
were not statistically significantly different between the
two types of nodules. Most of the MTC and PTC nodules
were classified as suspicious malignant; however, the
frequency of an indeterminate nodule was higher for the
MTCs than for the PTCs.
DISCUSSION
Eighty to ninety percent of MTCs have been considered
as sporadic and the rest have been classified as hereditary
(1). The familial form of the tumor usually occurs as a
component of type IIa MEN (Sipple syndrome), which is
characterized by the combination of an MTC, adrenal
pheochromocytoma and hyperplasia of the parathyroid
glands. MEN type IIb is a highly unusual form of the MEN
II syndrome and consists of elements of type IIa and
additional features of marfanoid habitus, mucosal
neuromas and intestinal ganglioneuromatosis. In the
present study, 16 patients were categorized as having the
sporadic form and two patients were categorized as having
MEN type IIa.
Fine needle aspiration (FNA) of thyroid nodules has
become one of the most useful, safe and accurate methods
used to diagnose thyroid pathology. US findings are
important to evaluate and prioritize nodules during FNA.
US findings have been reported to be of great help to distin-
guish malignant from benign nodules (6-11, 13). The US
findings that have been reported for malignant thyroid
nodules have included completely solid or predominantly
solid nodules, hypoechogenicity as compared with the strap
muscles, an irregular margin, intranodular microcalcifica-
tions, a taller than wide orientation and increased intran-
odular vascularity. Moon et al. (6) reported in a multicenter
retrospective study the US findings of benign and malignant
thyroid nodules (6). The Thyroid Study Group of the
KSNHNR organized this study, which was performed on
patients from nine university hospitals and large general
hospitals in the Republic of Korea. The findings suggested
malignancy in nodules with a taller than wide shape,
spiculated margin, marked hypoechogenicity, and intran-
odular calcifications (including microcalcifications or
macrocalcifications). The findings of the study
demonstrated a high sensitivity (93.8%) and a high
negative predictive value (95.9%). In most cases, the
malignant nodules that were included in the Moon et al. (6)
study and similar studies were PTCs, and most of the PTCs
correlated with the US findings of malignant thyroid
nodules (10-13). However, studies on the US findings of
MTC are not common (14, 15). Gorman et al. (14) reported
on the high-resolution US findings of MTC in 1987. All of
the tumors (six lesions in six patients) appeared hypoechoic
and were relatively well defined. Bright echogenic foci
were reported in five patients (83.3%), and this finding was
supported by the histological finding of focal deposits of
calcium surrounded by amyloid. In 2002, Saller et al. (15)
reported the US findings of 19 MTC cases. All of the cases
showed hypoechogenicity. The present study evaluated 21
MTC cases, a higher number than in previous studies. Most
MTC nodules (95.3%) were markedly hypoechoic (52%)
or hypoechoic (42.9%), and our findings are similar to the
findings of the above two studies (14, 15). In the current
study, intranodular calcifications were observed in 52% of
the MTC patients. As compared to the results of the
Gorman et al. (83.3%) and Saller et al. (95%) studies, we
found a low calcification rate.
Studies comparing the US findings of MTC with PTC
have not been previously conducted and we compared and
analyzed the US findings of 21 MTC cases and 114 PTC
cases. The mean size of MTC nodules was larger than that
of PTC nodules (19  13.9 mm vs. 11  7.5 mm, p <
0.05). In a comparison of the US findings, 57% of MTCs
and 25% of PTCs exhibited an ovoid to round shape,
which was significantly higher for the MTC nodules (p <
0.05). However, internal content, margin, echogenicity and
frequency of calcifications were not significantly different
between MTCs and PTCs. Most MTC (80.9%) and PTC
(93.9%) nodules were classified as suspicious malignant
Kim et al.
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Fig. 3. Ultrasonography performed on 51-year-old male with
papillary thyroid carcinoma.
Transverse scan shows 6 mm, solid, taller than wide, hypoechoic
nodule (arrow) with spiculated border and internal microcalcifica-
tions. This lesion was classified as suspicious malignant nodule.nodules. However, in a comparison of MTCs with PTCs,
suspicious malignant nodules were found less frequently
and indeterminate nodules were found more frequently in
MTC than in PTC. This finding can be attributed to a
significantly higher frequency of ovoid to round shape in
MTC, which is not a suspicious malignant feature. Both
MTCs and PTCs have been associated with calcifications
more than other thyroid malignancies. The association of
an MTC with amyloid deposition pathologically distin-
guishes this type of tumor from other thyroid malignancies
(16). Amyloid deposits may be associated with reactive
fibrosis and calcified deposits that give rise to characteristi-
cally dense, irregular foci throughout the tumor mass. This
observation is in contrast with the faint homogeneous
calcifications seen in other thyroid tumors (1). Dense and
irregular calcifications are known as a characteristic finding
of MTC; these macrocalcifications were seen in five MTC
nodules (23.8%) and in 21 PTC nodules (18.4%). Saller et
al. (15) defined calcifications longer than 2 mm as
macrocalcifications, and reported the presence of
macrocalcifications in 53% of MTC patients in their study;
this frequency was higher than in our study. Chan et al.
(11) found that among 55 PTC cases, 11% were associated
with macrocalcifications; this frequency was similar to the
frequency seen in the present study. The presence of
microcalcifications is a known characteristic finding of PTC
and microcalcifications have been reported in 29-59% of
all thyroid carcinomas (17). In our study, microcalcifica-
tions were found in 29% of MTCs and 47% of PTCs.
According to the findings in the study by Chan et al. (11),
42% of PTCs were associated with microcalcifications, a
finding that is similar to our results. Saller et al. (15)
reported that microcalcifications less than 2 mm in length
were seen in 42% of MTCs.
Serum calcitonin levels rise in MTC patients as MTCs are
derived from parafollicular C-cells that produce calcitonin (2).
However, not all MTCs secrete calcitonin and in particular,
more advanced tumors may dedifferentiate with a
subsequent decrease in calcitonin production (3). In the
present study, the basal calcitonin level was elevated in 14
patients and was within the normal range in one patient. The
patient with a normal calcitonin level had a huge, 7 cm
thyroid mass with an extensive necrotic lymph node metasta-
sis and perithyroidal soft tissue invasion. The pathological
result was a poorly differentiated pattern of MTC.
In conclusion, the common US features of MTC are a
solid internal content, an ovoid to round shape, marked
hypoechogenicity and calcifications. Most MTCs showed
US findings of suspicious malignant nodules, as reported
by the Thyroid Study Group of the KSNHNR. The US
findings were not greatly different between MTCs and
PTCs, except that the ovoid to round shape was more
abundant in MTCs.
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